Tag: Personalized Medicine
-
SoftBank Group and Tempus Establish “SB TEMPUS”
SoftBank Group Corp. 2024-06-27 SoftBank Group has formed a joint venture with Tempus AI, Inc. to establish “SB TEMPUS,” aiming to utilize medical data and AI for personalized healthcare in Japan. This initiative will collect and analyze fragmented medical data to support individualized medical treatments, particularly in cancer genomics. Source (Published: June 27, 2024)